Objective Acuity announces successful pilot study in children with CLN2 Batten disease

AUCKLAND, New Zealand, May 11, 2021 /PRNewswire/ -- Objective Acuity ("OAL") today announced the completion of a pilot study using OAL's threshold visual acuity test for young children diagnosed with late-infantile neuronal ceroid lipofuscinosis Type 2 (CLN2 disease), a form of Batten disease.

A prominent feature of CLN2 disease is vision...

Read more: Objective Acuity announces successful pilot study in children with CLN2 Batten disease

More Articles …

  1. Nayax Announces the Pricing of its Initial Public Offering
  2. Bionomics BNC210 Expansion into Social Anxiety Disorder
  3. Free online anti-harassment training launched by The College of Law and International Bar Association to make cultural change in the #MeToo era
  4. Aaseya Receives the Client Innovation Award for Social Responsibility from Pega
  5. UserTesting Research Finds Australians Express Caution Regarding Travel Bubble, and For Good Reason
  6. Vakrangee Enters The Online Space With The Launch Of Digital Services
  7. COVID Vaccine-Hesitant Consumers Care About Effectiveness Over Side-Effects
  8. Universities Leverage Latest in Automation to Migrate and Uplift Courses
  9. D'HYON WATCHES Kickstarter Launching 13th May
  10. Coa in Hong Kong is Named the Best Bar in Asia